Trump's Price Cuts For Obesity Drugs Raise More Questions Than Answers List of Interesting cards some may have forgotten (Casual MTG Deck) Connecticut is moving to eliminate Medicaid coverage of GLP 1 weight loss drugs like Ozempic and Mounjaro, a decision that could leave thousands of residents without access to medications that have transformed obesity Eli Lilly's Zepbound Gets FDA OK for Multi Dose Pen WSJ